FSMAX
Price
$111.98
Change
-$3.82 (-3.30%)
Updated
Jun 5 closing price
Net Assets
42.73B
PMPCX
Price
$13.60
Change
-$0.39 (-2.79%)
Updated
Jun 5 closing price
Net Assets
323.83M
Interact to see
Advertisement

FSMAX vs PMPCX

Header iconFSMAX vs PMPCX Comparison
Open Charts FSMAX vs PMPCXBanner chart's image
FSMAX vs PMPCX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. PMPCX commentary
Jun 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a StrongBuy and PMPCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 42.7B vs. PMPCX (324M). FSMAX pays higher dividends than PMPCX: FSMAX (0.50) vs PMPCX (0.00). FSMAX was incepted earlier than PMPCX: FSMAX (15 years) vs PMPCX (25 years). PMPCX (1.77) is less costly to investors than FSMAX (0.04). PMPCX is a more actively managed with annual turnover of: 80.00 vs. FSMAX (23.00). FSMAX (0) and PMPCX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 25.87 vs. PMPCX (-13.65). FSMAX return over 5 years is better than : 33.10 vs. PMPCX (-39.61).
FSMAXPMPCXFSMAX / PMPCX
Total Expense Ratio0.041.772%
Annual Report Gross Expense Ratio0.041.772%
Fund Existence15 years25 years-
Gain YTD11.2350.5172,171%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets42.7B324M13,179%
Annual Yield % from dividends0.500.00-
Returns for 1 year25.87-13.65-190%
Returns for 3 years66.08-1.59-4,151%
Returns for 5 years33.10-39.61-84%
Returns for 10 years133.38-19.21-694%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSBK41.590.30
+0.73%
Timberland Bancorp
PRPO23.490.13
+0.56%
Precipio
CDZIP22.44-0.31
-1.37%
Cadiz
QGEN36.68-0.88
-2.34%
Qiagen NV
NVAX9.49-0.70
-6.87%
Novavax